Health Condition 1: N915- Oligomenorrhea, unspecified Health Condition 2: N915- Oligomenorrhea, unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Married /unmarried patients in the age group of 18-40yrs 2. Patients with BMI >=30kg/m2 3. Patients with any 3 or more clinical features of PCOD like- • Amenorrhea or Oligomenorrhoea • Anovulation • Infertility (Due to anovulation) • Acne • Hirsutism (Ferryman-Gallwey scale) • Acanthosis nigricans. 4. Along with confirmation of Polycystic Ovary in USG finding
Exclusion criteria
Exclusion criteria: 1. Patients having age =40years. 2. Patient with infectious diseases of reproductive tract like tuberculosis, sexually transmitted diseases. 3. Patients suffering from Pelvic diseases like Endometriosis, PID, Fibroid uterus. 4. Organic lesions of reproductive tract like tuberculosis, carcinoma and congenital deformities. 5. Patients with history of cardiac diseases, Chronic liver disease, Uncontrolled Diabetes (>=160 mg/dl- FBS) & Hypertension (Systolic BP >=160 & Diastolic >=100mmhg), TB, etc 6. Patient with Hepatitis C, Hepatitis B 7. Patient not eligible for Virechana Karma.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected that trial drug will help in the reduction of ovarian volume,weight reduction and menstrual regulation.Timepoint: 120 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Trial drug will help in ovulation & conception.Timepoint: 120 days | — |
Countries
India
Contacts
INSTITUTE OF TEACHING AND RESEARCH IN AYURVEDA JAMNAGAR GUJRAT